Novo Nordisk bought Forma Therapeutics Forma Therapeutics Holdings from 10/14/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Novo Nordisk bought Forma Therapeutics for $1.1 billion, or $20 a share.

Forma Therapeutics Holdings

Review

Source:

{source} pictogram

ir.formatherapeutics.com

Vladimir Petenev

News editor

Write your comment first

News feed

McDonald's reported for 9 months of 2023

10/30/23 MCD

TNS Energo Mari El reported for 9 months of 2023 by RAS

10/30/23 MISB

Check Point reported for 9 months of 2023

10/30/23 CHKP

Belon reported for 9 months of 2023 by RAS

10/30/23 BLNG

Stavropolenergosbyt reported for 9 months of 2023 by RAS

10/30/23 STSB

TNS Energo Rostov-on-Don reported for 9 months of 2023 by RAS

10/30/23 RTSB

Electrozinc reported for 9 months of 2023 by RAS

10/30/23 ELTZ

Mosenergo reported for 9 months of 2023 by RAS

10/30/23 MSNG

LSR reported for 9 months of 2023 by RAS

10/30/23 LSRG

NCSP reported for 9 months of 2023 by RAS

10/30/23 NMTP